Top 50 Medical Device Startup Investors in Australia in May 2026

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Pre-Seed, Series A
Australia, United States, Hong Kong

Portfolio highlights

CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
CLIQ — We understand firsthand the impact of social isolation and the longing for genuine human connection. CLIQ was born from a vision to address this issue and to fundamentally transform the way that we meet new people and form connections.
Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.

Show all investments...

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Investment focus

Biotechnology, Health Care, Medical
Series A, Seed, Series B
Australia, United States, United Kingdom

Portfolio highlights

Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.

Show all investments...

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Investment focus

Software, SaaS, Health Care
Seed, Angel, Series A
Australia, United States

Portfolio highlights

Okkular — Okkular is an AI based fashion tech startup.
iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.

Show all investments...

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

Investment focus

Health Care, Manufacturing, Software
Funding Round, Series A, Seed
Australia, United States, Philippines

Portfolio highlights

EntroMat — EntroMat is a pioneering deep-tech startup transforming the metal powder industry through the advancement of high entropy material (HEM) powders.
Fyton Bio — FytonBio is a privately held, preclinical-stage biopharmaceutical company specializing in biotechnology research. Their core mission is to achieve functional cures for autoimmune and inflammatory diseases by deleting pathogenic immune cells. The company focuses on developing monoclonal antibodies capable of highly specific depletion of such cellsto durably alter disease progression.
Myostellar — Myostellar is creating a first-in-class, highly differentiated biologic therapy that stimulates muscle stem cells to promote muscle regeneration with no fibrosis.

Show all investments...

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

Investment focus

Biotechnology, Information Technology, Internet
Angel, Seed, Funding Round
Australia, United States, New Zealand

Portfolio highlights

Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.

Show all investments...

Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy

Investment focus

Manufacturing, Software, Health Care
Seed, Series A, Funding Round
Australia

Portfolio highlights

Wavewise Analytics — Cyban is a medical equipment manufacturing company that manufactures brain oxygen monitors.
Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
Visionary Machines — Superior perception for next-generation autonomy

Show all investments...

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Investment focus

Biotechnology, Health Care, Manufacturing
Series A, Seed, Series B
Australia, United States, United Kingdom

Portfolio highlights

Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
VeriQuantix — VeriQuantix was spun out of the University of Queensland. VeriQuantix is an Australian startup specializing in cybersecurity, focusing on quantum technology to enhance the security of optical fiber communication networks. Their core innovation, Quantum Link Verification (QLV), is designed to detect and alert network operators to physical tappingattempts and intercept cyber attacks on fiber optic networks. This technology leverages quantum principles, specifically entangled photons, to verify the trustworthiness of network links by ensuring that any unauthorized access disrupts photon entanglement and triggers immediate alerts.
Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.

Show all investments...

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Investment focus

Health Care, Medical Device, Biotechnology
Funding Round, Series A, Seed
Australia, United States, The Netherlands

Portfolio highlights

Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.

Show all investments...

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Investment focus

Software, Financial Services, FinTech
Funding Round, Series B, Convertible Note
Australia, United States, United Kingdom

Portfolio highlights

Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.

Show all investments...

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Investment focus

Biotechnology, Health Care, Manufacturing
Series A, Seed, Funding Round
Australia, United States, United Kingdom

Portfolio highlights

BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com

Show all investments...

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Investment focus

Health Care, Biotechnology, Medical Device
Series B, Series C, Funding Round
United States, India, Austria

Portfolio highlights

Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.

Show all investments...

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series B, Series A, Series C
United States, Australia, United Kingdom

Portfolio highlights

Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.

Show all investments...

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

Investment focus

Software, Artificial Intelligence, SaaS
Seed, Series A, Pre-Seed
Australia, United States, New Zealand

Portfolio highlights

Syenta — Syenta is transforming the electronics manufacturing sector. Our patented fabrication method enables the 3D printing of multi-material electronics with fewer steps and less waste.
Blinq — Blinq makes it easy to share your contact details via QR code scanning on the mobile app.
Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com

Show all investments...

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Investment focus

Software, Enterprise Software, Internet
Series A, Series B, Funding Round
United States, Australia, Philippines

Portfolio highlights

Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.

Show all investments...

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Investment focus

Software, Health Care, Biotechnology
Series A, Debt Financing, Funding Round
Australia, United States, Israel

Portfolio highlights

Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
StrongDM — Manage access to any server, database, or Kubernetes instance in minutes. Fully auditable, replayable, secure, and drag-and-drop easy.
Employment Hero — Recruitment, HR, Payroll & Benefits in one place - designed for small & medium businesses to be efficient, compliant & cost-Effective. Book a demo today!

Show all investments...

We're an early-stage venture capital firm investing in technology companies at the Seed and Series A stage.

Investment focus

Software, Developer Tools, Apps
Seed, Series A, Funding Round
Australia, Canada, United Kingdom

Portfolio highlights

Amaka — Accounting integrations and automation solutions for SMBs. Sync data from POS and e-commerce business apps to Xero, QuickBooks, MYOB and more.
Riparide — Riparide helps you plan and book your next escape through our Storyteller travel guides. These guides, called Riparide Stories, come packed with unique stays, local adventures and social vibes....
Lasertrade — Lasertrade is an online marketplace that offers a wide range of medical devices and equipment for the healthcare sector.

Show all investments...

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Investment focus

Software, Real Estate, Financial Services
Seed, Series A, Funding Round
Australia, Germany, United States

Portfolio highlights

MadeComfy — Award-winning Airbnb management service in Australia and New Zealand. MadeComfy is a selected official partner of Airbnb. Find out how we earn you higher returns with short-term rentals.
Futurerent — Futurerent is a tool that offers solutions to residential property investors for investment capital and cashflow needs.
Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.

Show all investments...

Skip Capital is a private investment fund investing in technology and infrastructure

Investment focus

Software, Artificial Intelligence, SaaS
Series A, Seed, Series B
Australia, United States, Canada

Portfolio highlights

Neara — Beyond visualization. A geometrically precise, 3D model that reveals how assets behave and react in the real world
Adora — Every user-journey, every screen, every interaction. Your entire product mapped for you in real-time, overlaid with analytics and replays.
Alloy — Alloy enables robotics teams to organise, explore, and evaluate various sorts of multimodal robot data in one platform using natural language, without the need for labels.

Show all investments...

Avicella Capital is to identify and finance commercial ventures that ethical and creative entrepreneurs have created to enhance patient outcomes and raise the standard of healthcare.

Investment focus

Therapeutics, Biotechnology
Series B
Australia

Portfolio highlights

Faeth Therapeutics — Home | Faeth
Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Convergence Medical Robotics — Convergence Medical Robotics is a Brisbane-based pre-clinical medical robotics company making arthroscopy better through the invention of the V01 Robot. It solves the complexity of arthroscopy by creating the world's first arthroscopic robot.

Show all investments...

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

Investment focus

Software, Information Technology, E-Commerce
Seed, Angel, Funding Round
Australia, United States, New Zealand

Portfolio highlights

Tendl — Write tenders faster with Tendl's AI tool. Keep your data private and secure. Easy installation, no sharing. Boost productivity and streamline your contract opportunities.
Shopfront — Automate multi-channel selling across eBay, Depop, Grailed & Shopify. AI-powered listings, bulk uploads, inventory sync.
Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.

Show all investments...

We are a community focused fund and syndicate investing in frontier mental health: psychedelics, neurotech, precision psychiatry, digital therapeutics, holistic medicine, metabolic psychiatry, digital health, and artificial intelligence.

Investment focus

Health Care, Biotechnology, Medical
Seed, Series A, Funding Round
United States, Canada, Israel

Portfolio highlights

Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
Sanmai — Sanmai is a neurotechnology company developing non-invasive ultrasound neurotherapeutics for mental health and neurological disorders
Jimini Health — Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.

Show all investments...

FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.

Investment focus

Medical, Health Care, Medical Device
Seed, Series A
Australia

Portfolio highlights

personr — Single source of truth for AML compliance
Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
VitalTrace — VitalTrace develops advanced biosensor technology to support safer childbirth. Our real-time fetal monitoring system helps detect distress during labour, empowering clinicians with data-driven decisions for better outcomes.

Show all investments...

Andrew R Banks

Investment focus

Grocery, Medical, Health Care
Seed
Australia

Portfolio highlights

Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.

Show all investments...

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Debt Financing
United Kingdom, Australia, United States

Portfolio highlights

IQ Endoscopes — Fully Disposable Endoscopes for General Medical Use. A successful initial investment funding round completed, we are seeking future funding to take the IQ Scope to market.
ADC Biotechnology — Temukan prediksi Macau 4D 5D akurat di situs kami! Dapatkan bocoran togel toto Prediksi Macau Hari ini, dirumuskan oleh master prediktor. Bandingkan analisa Anda dan manfaatkan prediksi kami untuk meningkatkan peluang kemenangan Anda. Bergabunglah dengan kami untuk meraih JP impian. Salam JP
Community Energy Pembrokeshire — Temukan cara menangkap cuan di lautan dengan ORCA128! Bergabunglah dengan kami untuk strategi dan tips terbaik dalam dunia perikanan.

Show all investments...

Sirius Capital is a venture capital firm in China that invests in technology companies.

Investment focus

Artificial Intelligence, Video, Retail
Series A, Seed, Series C
China, Australia

Portfolio highlights

Vantari VR — Virtual Reality for Healthcare
Vastai Technologies — Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.
Kuanfen Technology Realcome — Kuanfen Technology Realcome is a brand of AI virtual bloggers that focuses on the use of various AI technologies.

Show all investments...

Anova Capital focus on investment in education, big health and new consumption.

Investment focus

Education, Rental, Travel
Series A, Seed
China, Australia

Portfolio highlights

Qukoucai — Qukoucai is an online interactive learning platform for children and children. It focuses on providing customized online personal eloquence courses for 4-12 years old children. It includes a complete closed-loop product of teaching, practice, evaluation and display, and is committed to improving children's eloquence. ability.
Vantari VR — Virtual Reality for Healthcare
Woody Library — Woody Library is the first subscription-based book sharing and rental platform in China. In the cabin, you can spend the least amount of money, read the most books, and never again, the book that bought the hand has turned over a few pages and found that it has no long-term collection value.

Show all investments...

Learn how we find, fund and support high-impact innovations

Investment focus

Health Care, Medical Device, Biotechnology
Grant, Seed, Debt Financing
Canada, United States, Australia

Portfolio highlights

Hewatele — Hewatele is a social enterprise that provides affordable quality medical oxygen to all needy patients together with its affiliates CPHD and Mediquip Global.
LegWorks — LegWorks Knees are high-functioning, waterproof, and stable prosthetic devices that fulfill the security needs of low mobility users while still meeting the rugged demands of a highly active amputee.
Nivi — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.

Show all investments...

Investing in the deep science and technology that can propel humanity towards a radically better future.

Investment focus

Biotechnology, Artificial Intelligence, Software
Series A, Series B, Seed
United States, United Kingdom, Canada

Portfolio highlights

Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.

Show all investments...

Archangel is an early stage venture capital fund based in Australia. We work with great founders and investors to build game changing companies together.

Investment focus

Software, Artificial Intelligence, SaaS
Seed, Pre-Seed, Series A
Australia, United States, Philippines

Portfolio highlights

GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
Termina — Termina operates as an energy tech startup.

Show all investments...

Privately Held Companies

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Series C
United States, Canada, Australia

Portfolio highlights

OutcomesAI — OutcomesAI operates as a healthcare company, that combines AI Voice Agents with licensed nurses to deliver safe, scalable care across health systems.
ABK Biomedical — At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors
Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.

Show all investments...

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

Investment focus

SaaS, Software, Health Care
Seed, Pre-Seed, Series A
Australia, United States

Portfolio highlights

Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
Kapiche — Customer intelligence for CX, support and product teams who need to understand their customers accross more than just surveys. Analyze 100% of customer conversations to prevent churn and accelerate growth.
Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.

Show all investments...

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B
Australia

Portfolio highlights

Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.

Show all investments...

Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.

Investment focus

Medical, Health Care, Medical Device
Series A
Australia

Portfolio highlights

Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.

Show all investments...

Powerhouse Ventures backs entrepreneurs building the digital infrastructure for rapid decarbonization.

Investment focus

Software, Energy, Solar
Seed, Series A, Pre-Seed
United States, Australia, United Kingdom

Portfolio highlights

Zeti — Enabling the scale up of real world assets essential to the energy transition by connecting operators and institutional capital through simple, technology powered finance.
CapeZero — CapeZero is a software-as-a-service company providing financial technology solutions to counterparties evaluating investment, financing, and sale options for clean energy projects. Almost every renewable energy project benefits from receiving a “structured tax credit investment” (i.e. tax equity, transferability, and direct pay). CapeZero’smodeling and deal analysis software provides developers, investors, and advisors with a platform to efficiently navigate structured tax credit investments. CapeZero enables stakeholders to make real-time, profit-optimizing decisions and build a clean energy future together.
ThinkLabs AI — ThinkLabs AI is a specialist AI development and deployment firm. Its mission is to empower critical industries and infrastructure with trustworthy AI towards global energy sustainability.

Show all investments...

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Investment focus

Software, Artificial Intelligence, Information Technology
Pre-Seed, Seed, Funding Round
United Kingdom, United States, Canada

Portfolio highlights

ZERØTEC — ZERØTEC is an pattern design and nesting software platform for fashion designers and manufacturers
Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
Srotas Health — Join thousands of patients, researchers, and healthcare organizations advancing medical breakthroughs. Streamline clinical trials with our cutting-edge platform.

Show all investments...

Only a few year ago, it took $ millions to get a tech venture to market; $1m before cutting a line of code, another $1m or so to get v1.0 into customers hands, millions more refining it.That was for a start up. Multiply it times over for a large corporate.Then, assuming it was a product people used/wanted, millions to scale it. If theproduct/market fit wasn't there, millions more to pivot, chase a business model.Today ideas can be conceived, tested, architected, teams added, capabilities assembled, services built, deployed, at scale, globally for a fraction of the cost and time.Venture-Store is founded upon this profound shift: ideas with unicorn scale, potential, shipped to market rapidly, inexpensively, by anyone from anywhere in the world.The scale, sophistication and configurability of tech is fuelling unprecedented innovation throughout business and society. Markets are up for grabs, open to new, better ways of solving problems and creating value for consumers. For entrepreneurs, start ups, corporations and investors the game is changing. Earlier access to new ventures is more important than ever to investment returns.

Investment focus

Wellness, Blockchain, Health Care
Seed
Australia

Portfolio highlights

Helfie.ai — Helfie AI is a groundbreaking mobile platform that enables easy, instant and affordable health checks for a wide range of conditions. Helfie-Backed by science.

Show all investments...

The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Pre-Seed, Funding Round
Australia, United States, India

Portfolio highlights

LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.

Show all investments...

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B
Australia

Portfolio highlights

Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable pointâ€ofâ€care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.

Show all investments...

A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.

Investment focus

Health Care, Medical Device
Series A
Australia

Portfolio highlights

Baymatob — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.

Show all investments...

Co:Act is an investment partnership of experienced venture investors with a network of founders.

Investment focus

Advice, Hospital, Software
Series A, Funding Round
Australia

Portfolio highlights

Veyor — The leading live scheduling app for the built environment, helping dispersed teams and their suppliers plan, manage and track daily activity on an easy to use mobile and desktop platform.
Knocknoc — Cybersecurity software company specialising in attack surface reduction technologies
Vantari VR — Virtual Reality for Healthcare

Show all investments...

The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

Investment focus

Sensor, Medical, Wearables
Funding Round
Australia

Portfolio highlights

Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.

Show all investments...

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Show all investments...

Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.

Investment focus

Software, Information Technology, SaaS
Seed, Funding Round, Pre-Seed
United States, India, Canada

Portfolio highlights

VitVio — VitVio is a platform built around AI and computer vision with the goal of improving efficiency and quality of care in operating rooms.
UniPay — UniPay is an eCommerce platform for infrastructure and industry-lacking regions that offers 5 products that enable trust, promote transparency, and enforce accountability.
Emission Sentri — Drive emission management and reduction with insights

Show all investments...

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

Investment focus

Software, Health Care, Biotechnology
Seed
Australia

Portfolio highlights

Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.

Show all investments...

A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.

Investment focus

Health Care, Biotechnology, Medical Device
Seed
Australia

Portfolio highlights

Ferronova — Ferronova is a medical device company that offers imaging and surgery products.

Show all investments...

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

Investment focus

Software, Health Care, Machine Learning
Seed, Funding Round, Series A
United States, Colombia, India

Portfolio highlights

Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!

Show all investments...

Right Click Capital - Australian Venture Capital Firm

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Australia, Singapore, United States

Portfolio highlights

black.ai — Build smarter spaces with Black.ai
Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation

Show all investments...

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

Investment focus

Health Care, Biotechnology, Internet of Things
Seed, Series B, Funding Round
Australia

Portfolio highlights

Fivecast — Fivecast is a global provider of open-source intelligence solutions, providing access and analysis of unprecedented amounts of digital data
Seonix Bio — Seonix Bio is dedicated to helping health professionals, individuals and researchers understand glaucoma risk using genetics.
Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.

Show all investments...